Quest Diagnostics Inc. (United States) is listed on the NYSE and has a market capitalization of $23.20 billion, with shareholders equity totaling $7.75 billion.
The company employs approximately 47.000 people and operates in the Health sector, within the Health Establishments industry.
Over the past 12 months, Quest Diagnostics Inc. reported $11.28 billion in revenue, generating net income of $1.02 billion.
Key financial metrics include a P/E ratio of 22.66, a price-to-book (P/B) ratio of 3.00, and a trailing twelve-month dividend yield of 1.55%.
The company trades under the ticker DGX.